A phase I dose escalation study of PRS-343, a HER2/4-1BB bispecific molecule, in patients with HER2-positive malignancies Meeting Abstract
| Authors: | Ku, G.; Bendell, J. C.; Tolcher, A. W.; Hurvitz, S. A.; Krishnamurthy, A.; El-Khoueiry, A. B.; Patnaik, A.; Shroff, R. T.; Noonan, A.; Hahn, N. M.; Matrana, M.; Zettl, M.; Aviano, K.; Mar, L.; Jolicoeur, P.; Olwill, S.; Bruns, I.; Piha-Paul, S. |
| Abstract Title: | A phase I dose escalation study of PRS-343, a HER2/4-1BB bispecific molecule, in patients with HER2-positive malignancies |
| Meeting Title: | ESMO Virtual Congress 2020 |
| Journal Title: | Annals of Oncology |
| Volume: | 31 |
| Issue: | Suppl. 4 |
| Meeting Dates: | 2020 Sep 19-21/Oct 16-18 |
| Meeting Location: | Virtual |
| ISSN: | 0923-7534 |
| Publisher: | Oxford University Press |
| Date Published: | 2020-09-01 |
| Start Page: | S462 |
| End Page: | S463 |
| Language: | English |
| ACCESSION: | WOS:000573469100523 |
| DOI: | 10.1016/j.annonc.2020.08.639 |
| PROVIDER: | wos |
| Notes: | Meeting Abstract: 525O -- Source: Wos |
